results when the initial urinary steroid excretion (17-KGS, 17-OHCS) is low. The response may be negative in patients with myxoedema, liver disease or pregnancy or when certain drugs are given such as cestrogens, anabolic steroids or chlorpromazine. Further, because of the marked diurnal sensitivity to metyrapone administration it is most important that a suitable dose be given at midnight and at 4 a.m. or a false negative result may be obtained.
Insulin hypoglycwemia is of great value in testing the hypothalamic-pituitary-adrenal axis but it must be carried out with due attention to its limitations. It is important that the fasting plasma glucose is reduced to at least 40% of its initial value within twenty to thirty minutes of the administration of the insulin. Hypoglycaemia of less intensity may fail to elicit a response. Patients with obesity and Cushing's disease may be unresponsive as are patients who have previously received glucocorticoids. The test must be carried out under skilled medical supervision and otherwise is unsuitable as a screening procedure.
Lysine 
